Skip to content
Home/Companies/Biotech/EOS (Ethical Oncology Science)

EOS (Ethical Oncology Science)

Biotech·Italy·Exited 2013·Held 4yr
Entry
2009
Hold
4yr
Exit
2013

Who owns EOS (Ethical Oncology Science)?

EOS (Ethical Oncology Science) was owned by Principia SGR through Principia Fund (2007 vintage) from 2009 to 2013, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-26

Principia SGR
Investor
Principia SGR
Principia Fund · 2007 · VC

Key facts

HQItaly
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2013

More from Principia Fund

Other portfolio companies in the same fund.

Banzai
Exited 2015
E-commerceItaly· 2010
Pharmeste
Active
PharmaItaly· 2007

More Principia SGR portfolio companies

From the same investor, across funds.

Comftech
Active
MedTechItaly· 2018
Compass Pathways
Compass Pathways
Exited 2020
BiotechUnited Kingdom· 2018
CrestOptics
CrestOptics
Active
MedTechItaly· 2018
Enterome
Enterome
Active
BiotechFrance· 2018
Gada
Gada
Active
MedTechItaly· 2018
Trifarma
Trifarma
Active
PharmaItaly· 2017

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track EOS (Ethical Oncology Science)

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on EOS (Ethical Oncology Science).

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue